Stock Report

All about this stock under one free report Last Updated: 12-May-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Lucira Health Inc. (LHDX)

Stock Card factsheet share-fund-plan-icon

$0.03

up-down-arrow $-0.01 (-19.29%)

As on 05-May-2023 09:30EDT

Market cap

info icon

$18 Mln

Revenue (TTM)

info icon

$212 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.2

Div. Yield

info icon

0 %

Lucira Health (LHDX) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.03 High: 0.04

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-143 Mln

  • ROEROE information

    -1.1 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    44.03

  • EV/EBITDAEV/EBITDA information

    -0.1

  • Debt to EquityDebt to Equity information

    0.5

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    40,599,000

Years Aggregate

CFO

$--

EBITDA

$--

Net Profit

$--

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Lucira Health (LHDX)
-69.5 -83.8 -90.0 -98.9 -- -- --
BSE Sensex*
-11.9 -3.9 -11.5 -6.2 6.4 8.7 11.3
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 05-May-2023  |  *As on 12-May-2026  |  #As on 26-Oct-2023
Company
2022
Lucira Health (LHDX)
-98.7
S&P Small-Cap 600
-17.4
BSE Sensex
4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
Quarterly Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Annual

*All values are in ($ Mln)

Key Ratios

View Details

5Y Avg -- 3Y Avg -- TTM --

P/E Ratio

--

--Min --Median --Max

P/B Ratio

--

--Min --Median --Max

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

Peers

View Details
Company
 Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Lucira Health (LHDX)
0.0 18.4 212.1 -143.3 -66.8 -107.9 -- 0.2
Cardiovascular Systems (CSII)
20.0 844.0 239.8 -37.9 -16.1 -15.5 -- 2.4

Shareholding Pattern

View Details
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Lucira Health (LHDX)

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19...  All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.  Read more

  • Pres, CEO & Director

    Mr. Erik T. Engelson

  • Pres, CEO & Director

    Mr. Erik T. Engelson

  • Headquarters

    EmeryVille, CA

  • Website

    https://www.lucirahealth.com

Value Research Ratings

Our rating system has guided millions of investors in the past 20 years.

Top Rated Stocks

All stocks with 5-star Value Research Ratings

Top Rated Stocks Icon

High Quality Small Caps

Small-cap stocks rated high on quality score

High Quality Small Caps Icon

High Growth Large Caps

Large-cap stocks with a high growth score

High Growth Large Caps Icon

Value Meets Momentum

Top momentum stocks with a high valuation score

Value Meets Momentum Icon

Top Rated Banks

Banks that rate high on Value Research Stock Ratings

Top Rated Banks Icon
Explore Screeners
Edit peer-selector-edit

FAQs for Lucira Health (LHDX)

The share price of Lucira Health Inc (LHDX) is $0.03 (NASDAQ) as of 05-May-2023 09:30 EDT. Lucira Health Inc (LHDX) has given a return of -98.91% in the last 1 years.

Since, TTM earnings of Lucira Health Inc (LHDX) is negative, P/E ratio is not available.
The P/B ratio of Lucira Health Inc (LHDX) is 0.19 times as on 05-May-2023, a 94 discount to its peers’ median range of 3.03 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2021
--
--
2020
--
--
2019
--
--
2018
--
--
2021
--
--

The 52-week high and low of Lucira Health Inc (LHDX) are Rs -- and Rs -- as of 12-May-2026.

Lucira Health Inc (LHDX) has a market capitalisation of $ 18 Mln as on 05-May-2023. As per SEBI classification, it is a Small Cap company.

Before investing in Lucira Health Inc (LHDX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.